Synlett 2019; 30(17): 2004-2009
DOI: 10.1055/s-0039-1690204
letter
© Georg Thieme Verlag Stuttgart · New York

Discovery of Novel Approach for Regioselective Synthesis of Thioxotriaza-Spiro Derivatives via Oxalic Acid

Vindya K. Gopinatha
a   Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru-570006, India
,
Hassan A. Swarup
a   Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru-570006, India
,
Sathees C. Raghavan
b   Department of Biochemistry, Indian Institute of Science, Bangalore-560012, India   Email: rangappaks@gmail.com   Email: kmlingu@gmail.com
,
Kempegowda Mantelingu
a   Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru-570006, India
,
Kanchugarakoppal S. Rangappa
a   Department of Studies in Chemistry, Manasagangotri, University of Mysore, Mysuru-570006, India
› Author Affiliations
Financial support from the DBT Glue grant No. BT/PR23078/MED/29/1253/2017 dated 22/03/2018 is gratefully acknowledged. We are thankful to the Council of Scientific and Industrial Research (CSIR), grant No. 09/119(0200)/2015-EMR-I, for providing a Senior Research Fellowship to V.K.G.
Further Information

Publication History

Received: 15 July 2019

Accepted after revision: 10 September 2019

Publication Date:
24 September 2019 (online)


Abstract

A vital approach for the synthesis of a range of novel thioxotriaza-spiro derivatives is described. These new heterocyclic systems are obtained via oxalic acid catalyzed reaction of α,β-unsaturated ketones in the presence of 5,6-diamino-2-mercaptopyrimidine-4-ols; thus, spiro rings are constructed in one step. Notably, this transformation involves condensation of an amino group followed by enamine reaction with alkenes and subsequent reaction promoted by oxalic acid to afford spiro compounds with excellent regioselectivity.

Supporting Information

 
  • References and Notes

    • 1a Pradhan R, Patra M, Behera AK, Mishra BK, Behera RK. Tetrahedron 2006; 62: 779
    • 1b Stotani S, Lorenz C, Winkler M, Medda F, Picazo E, Ortega Martinez R, Karawajczyk A, Sanchez-Quesada J, Giordanetto F. ACS Comb. Sci. 2016; 18: 330
    • 2a Molvi KI, Haque N, Awen BZ. S, Zameeruddin M. World J. Pharm. Pharm. Sci. 2014; 3: 536
    • 2b Zheng YJ, Tice CM. Expert Opin. Drug Discovery 2016; 11: 831
  • 3 Zheng Y, Tice CM, Singh SB. Bioorg. Med. Chem. Lett. 2014; 24: 3673
    • 4a Ryzhakov D, Jarret M, Guillot R, Kouklovsky C, Vincent G. Org. Lett. 2017; 19: 6336
    • 4b Shao PL, Li ZR, Wang ZP, Zhou MH, Wu Q, Hu P, He Y. J. Org. Chem. 2017; 82: 10680
    • 4c Piou T, Neuville L, Zhu J. Org. Lett. 2012; 14: 3760
    • 4d Smith AC, Cabral S, Kung DW, Rose CR, Southers JA, García-Irizarry CN, Damon DB, Bagley SW, Griffith DA. J. Org. Chem. 2016; 81: 3509
  • 5 Vartak SV, Swarup HA, Gopalakrishnan V, Gopinatha VK, Ropars V, Nambiar M, John F, Kothanahally SK. S, Kumari R, Kumari N, Ray U, Radha G, Dinesh D, Pandey M, Ananda H, Karki SS, Srivastava M, Charbonnier JB, Choudhary B, Mantelingu K, Raghavan SC. FEBS J. 2018; 1
  • 6 Srivastava M, Nambiar M, Sharma S, Karki SS, Goldsmith G, Hegde M, Kumar S, Pandey M, Singh RK, Ray P, Natarajan R, Kelkar M, De A, Choudhary B, Raghavan SC. Cell 2012; 151: 1474
    • 7a Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kühn R. Nat. Biotechnol. 2015; 33: 543
    • 7b Singh P, Schimenti JC, Bolcun-Filas E. Genetics 2015; 199: 1
    • 7c Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Nat. Biotechnol. 2015; 33: 538
    • 7d Vartak SV, Raghavan SC. FEBS J. 2015; 282: 4289
    • 8a Gopalakrishnan V, Radha G, Raghavan S, Choudhary B. J. Radiat. Cancer Res. 2018; 9: 93
    • 8b Kumar A, Bhatkar D, Jahagirdar D, Sharma NK. J. Cancer Prev. 2017; 22: 47
    • 8c Reid DA, Keegan S, Leo-Macias A, Watanabe G, Strande NT, Chang HH, Oksuz BA, Fenyo D, Lieber MR, Ramsden DA, Rothenberg E. Proc. Natl. Acad. Sci. U.S.A. 2015; 112: E2575
    • 8d Yang Z, Chen S, Xue S, Li X, Hu J, Sun Z, Cui H. Onco. Targets. Ther. 2018; 11: 4945
    • 9a Kumar SV, Yadav SK, Raghava B, Saraiah B, Ila H, Rangappa KS, Hazra A. J. Org. Chem. 2013; 78: 4960
    • 9b Raghava B, Parameshwarappa G, Acharya A, Swaroop TR, Rangappa KS, Ila H. Eur. J. Org. Chem. 2014; 1882
    • 9c Mantelingu K, Lin Y, Seidel D. Org. Lett. 2014; 16: 5910
    • 9d Hegde M, Mantelingu K, Swarup HA, Pavankumar CS, Qamar I, Raghavan SC, Rangappa KS. RSC Adv. 2016; 6: 6308
    • 9e Pavan Kumar CS, Harsha KB, Mantelingu K, Rangappa KS. RSC Adv. 2015; 5: 61664
    • 9f Pavan Kumar CS, Harsha KB, Sandhya NC, Ramesha AB, Mantelingu K, Rangappa KS. New J. Chem. 2015; 39: 8397
  • 10 Ramirez J, Svetaz L, Quiroga J, Abonia R, Raomondi M, Zacchino S, Insuasty B. Eur. J. Med. Chem. 2015; 92: 866
  • 11 CCDC 1888913 contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
  • 12 Synthesis of 8-Thioxo-1,7,9-trizaospiro[4,5]dec-1-ene-6,10-dione Analogues A mixture of α,β-unsaturated ketone (1 mmol), 5,6-diamino-2-mercaptopyrimidin-4-ol (1 mmol), and oxalic acid (20 mol%) was taken in an Ace Pressure tube, and the reaction mixture was heated at 120 °C for 16 h. After completion of the reaction (monitored by TLC), DMF (1 mL) was added to the gummy reaction mass and was stirred for 10 min at 120 °C to solubilize the reaction mass. The solution was cooled to room temperature and then poured into ice-cold water. The precipitate formed was filtered, dried, and purified by column chromatography using eluent ethyl acetate and hexane. All compounds were obtained as solids.
  • 13 Analytical Data 4-(4-Methoxyphenyl)-2-phenyl-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3a) Yield: 88%; off-white solid; mp 240–242 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.64 (s, 1 H), 12.14 (s, 1 H), 7.94 (d, J = 8 Hz, 2 H), 7.49–7.58 (m, 3 H), 7.10 (d, J = 8.8 Hz, 2 H), 6.86 (d, J = 9.2 Hz, 2 H), 4.08 (t, J = 9.6 Hz, 1 H), 3.02 (s, 3 H), 3.54–3.59 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 180.3, 169.6, 166.2, 159.3, 133.5, 132.2, 129.2, 129.1, 128.6, 127.3, 114.4, 85.5, 55.5, 55.2, 40.8. HRMS (ESI): m/z [M + H]+ calcd for C20H17N3O3S: 380.1024; found: 380.1026. 4-(4-Chlorophenyl)-2-phenyl-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3b) Yield: 85%; off-white solid; mp 155–157 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.67 (s, 1 H), 12.18 (s, 1 H), 7.94 (d, J = 7.2 Hz, 2 H), 7.49–7.59 (m, 3 H), 7.37 (d, J = 8.4 Hz, 2 H), 7.19 (d, J = 8.4 Hz, 2 H), 4.17 (t, J = 9.2 Hz, 1 H), 3.53–3.67 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 180.1, 179.1, 169.3, 166.0, 134.9, 133.1, 132.9, 132.3, 130.0, 129.1, 128.9, 128.6, 85.4, 54.4, 40.8. HRMS (ESI): m/z [M + H]+ calcd for C19H14ClN3O2S: 384.0495; found: 384.0498. 4-(4-Methoxyphenyl)-2-(thiophen-2-yl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3c) Yield: 87%; off-white solid; mp 205–207 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.74 (s, 1 H), 12.27 (s, 1 H), 7.86 (d, J = 8.8 Hz, 2 H), 7.44 (dd, J = 5, 1.4 Hz, 1 H), 7.03 (d, J = 8.8 Hz, 2 H), 6.96–6.98 (m, 2 H), 4.34 (dd, J = 11.2, 8.8 Hz, 1 H), 3.81 (s, 3 H), 3.73 (dd, J = 16.6, 8.6 Hz, 1 H), 3.47 (dd, J = 16.6, 11 Hz, 1 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.1, 169.4, 166.1, 166.0, 162.6, 138.3, 130.5, 127.6, 126.6, 126.0, 125.7, 114.5, 84.7, 55.8, 50.5, 42.4. HRMS (ESI): m/z [M + H]+ calcd for C18H15N3O3S2: 386.4600; found: 386.4606. 2-(4-Methoxyphenyl)-4-(thiophen-2-yl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3d) Yield: 86%; off-white solid; mp 230–232 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.61 (s, 1 H), 12.12 (s, 1 H), 7.84–7.85 (m, 1 H), 7.70 (d, J = 2.8 Hz, 1 H), 7.22 (dd, J = 5, 3.8 Hz, 1 H), 7.06 (d, J = 8.8 Hz, 2 H), 6.84 (d, J = 8.4 Hz, 2 H), 4.06 (t, J = 9.6 Hz, 1 H), 3.69 (s, 3 H), 3.51–3.55 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 178.5, 174.1, 169.0, 165.8, 158.8, 137.1, 132.7, 131.9, 128.7, 128.1, 126.6, 114.4, 84.6, 55.1, 40.8. HRMS (ESI): m/z [M + H]+ calcd for C18H15N3O3S2: 386.4600; found: 386.4606. 2,4-Diphenyl-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione(3e) Yield: 89%; off-white solid; mp 230–232 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.69 (s, 1 H), 12.16 (s, 1 H), 7.96 (d, J = 5.6 Hz, 2 H), 7.51–7.61 (m, 3 H), 7.27–7.33 (m, 3 H), 7.18 (d, J = 5.2 Hz, 2 H), 4.17 (t, J = 8 Hz, 1 H), 3.58–3.67 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 180.4, 179.1, 169.7, 166.2, 133.7, 132.4, 129.2, 129.1, 128.7, 128.4, 128.2, 85.5, 55.6, 39.9. HRMS (ESI): m/z [M + H]+ calcd for C19H15N3O2S: 350.4063; found: 350.4067. 4-(4-Chlorophenyl)-2-(4-methoxyphenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3f) Yield: 84%; off-white solid; mp 225–227 °C; 1H NMR (DMSO-d 6, 400 MHz): δ = 12.67 (s, 1 H), 12.17 (s, 1 H), 7.88 (d, J = 8.8 Hz, 2 H), 7.36 (d, J = 8.4 Hz, 2 H), 7.17 (d, J = 8.4 Hz, 2 H), 7.04 (d, J = 8.4 Hz, 2 H), 4.13 (t, J = 9.4 Hz, 1 H), 3.80 (s, 3 H), 3.48–3.62 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.3, 179.2, 169.6, 166.4, 162.6, 132.9, 130.6, 130.1, 129.0, 125.9, 114.5, 85.5, 54.4. 54.1, 40.7. HRMS (ESI): m/z [M + H]+ calcd for C20H16ClN3O3S: 414.8773; found: 414.8778. 4-(4-Chlorophenyl)-2-(thiophen-2-yl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3g) Yield: 86%; off-white solid; mp 210–212 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.65 (s, 1 H), 12.17 (s, 1 H), 7.85 (d, J = 4.4 Hz, 1 H), 7.70 (d, J = 2.8 Hz, 1 H), 7.36 (d, J = 8.4 Hz, 2 H), 7.22 (dd, J = 4.8, 4 Hz, 1 H), 7.17 (d, J = 8.4 Hz, 2 H), 4.16 (t, J = 9.4 Hz, 1 H), 3.51–3.64 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.1, 174.5, 169.2, 166.2, 137.4, 134.8, 133.4, 133.0, 132.6, 130.1, 129.1, 128.8, 85.5, 54.8, 41.3. HRMS (ESI): m/z [M + H]+ calcd for C17H12ClN3O2S2: 390.0059; found: 390.0063. 4-(4-Fluorophenyl)-2-phenyl-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3h) Yield: 88%; off-white solid; mp 208–210 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.69 (s, 1 H), 12.19 (s, 1 H), 7.96 (d, J = 7.2 Hz, 2 H), 7.51–7.59 (m, 3 H), 7.14–7.24 (m, 4 H), 4.17 (t, J = 9.4 Hz, 1 H), 3.54–3.68 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 180.2, 179.1, 169.3, 166.1, 133.2, 132.3, 130.2, 130.1, 129.1, 128.6, 115.9, 115.7, 85.5, 54.7, 40.9. HRMS (ESI): m/z [M + H]+ calcd for C19H14FN3O2S: 368.0791; found: 368.0795. 2-Phenyl-4-(thiophen-2-yl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3i) Yield: 89%; off-white solid; mp 166–168 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.78 (s, 1 H), 12.31 (s, 1 H), 7.92 (d, J = 7.2 Hz, 2 H), 7.56 (t, J = 7.4 Hz, 1 H), 7.49 (t, J = 7.4 Hz, 2 H), 7.44 (t, J = 3 Hz, 1 H), 6.97 (d, J = 2.4 Hz, 2 H), 4.36 (t, J = 9.4 Hz, 1 H), 3.76 (dd, J = 16.6, 8.6 Hz, 1 H), 3.51 (dd, J = 16.4, 10.8 Hz, 1 H). 13C NMR (DMSO-d6, 400 MHz): δ = 180.0, 179.2, 169.3, 165.8, 138.1, 133.0, 132.4, 129.1, 128.6, 127.7, 126.7, 126.1, 84.8, 50.6, 42.4. HRMS (ESI): m/z [M + H]+ calcd for C17H13N3O2S2: 356.4340; found: 356.4344. 2,4-Bis(4-methoxyphenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3j) Yield: 88%; off-white solid; mp 224–226 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.62 (s, 1 H), 12.12 (s, 1 H), 7.88 (d, J = 8.8 Hz, 2 H), 7.07 (d, J = 8.8 Hz, 2 H), 7.03 (d, J = 8.8 Hz, 2 H), 6.84 (d, J = 8.4 Hz, 2 H), 4.04 (t, J = 9.4 Hz, 1 H), 3.81 (s, 3 H), 3.69 (s, 3 H), 3.46–3.55 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.3, 179.1, 169.9, 166.5, 162.4, 159.2, 130.4, 129.2, 127.4, 126.0, 114.4, 114.3, 85.3, 55.8, 55.5, 55.2, 40.7. HRMS (ESI): m/z [M + H]+ calcd for C21H19N3O4S: 410.4583; found: 410.4587. 4-(Naphthalen-1-yl)-2-phenyl-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3k) Yield: 89%; off-white solid; mp 130–132 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.50 (s, 1 H), 12.95 (s, 1 H), 7.98–8.00 (m, 2 H), 7.84–7.92 (m, 3 H), 7.44–7.61 (m, 7 H), 5.05 (t, J = 9.2 Hz, 1 H), 3.74–3.79 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 180.3, 178.6, 169.9, 166.2, 133.8, 133.3, 132.3, 132.1, 131.4, 129.3, 129.2, 128.9, 128.7, 127.0, 126.1, 125.8, 125.7, 122.7, 85.2, 50.2, 42.3. HRMS (ESI): m/z [M + H]+ calcd for C23H17N3O2S: 400.4650; found: 400.4656. 2,4-Bis(4-chlorophenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3l) Yield: 84%; off-white solid; mp 223–225 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.71 (s, 1 H), 12.21 (s, 1 H), 7.98 (d, J = 8 Hz, 2 H), 7.61 (d, J = 4 Hz, 2 H), 7.40 (d, J = 8 Hz, 2 H), 7.21 (d, J = 4 Hz, 2 H), 4.19 (t, J = 8 Hz, 1 H), 3.60–3.64 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.3, 179.2, 169.3, 166.0, 137.0, 134.9, 133.0, 132.0, 130.5, 130.1, 129.4, 129.1, 85.6, 54.7, 40.8. HRMS (ESI): m/z [M + H]+ calcd for C19H13Cl2N3O2S: 418.2964; found: 418.2968. 2-(4-Chlorophenyl)-4-(4-fluorophenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3m) Yield: 84%; off-white solid; mp 184–186 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.67 (s, 1 H), 12.16 (s, 1 H), 7.94 (d, J = 8 Hz, 2 H), 7.58 (d, J = 8 Hz, 2 H), 7.12–7.20 (m, 4 H), 4.14 (t, J = 9.2 Hz, 1 H), 3.55–3.60 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.3, 179.0, 169.2, 166.0, 137.1, 132.0, 131.7, 130.4, 130.2, 130.1, 129.3, 115.9, 85.5, 54.8, 40.8. HRMS (ESI): m/z [M + H]+ calcd for C19H13ClFN3O2S: 402.0401; found: 402.0406. 2-(3-Bromophenyl)-4-(4-fluorophenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3n) Yield: 82%; off-white solid; mp 222–224 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.68 (s, 1 H), 12.17 (s, 1 H), 8.10 (s, 1 H), 7.93 (d, J = 7.6 Hz, 1 H), 7.78 (d, J = 8 Hz, 1 H), 7.49 (t, J = 8 Hz, 1 H), 7.21 (t, J = 7 Hz, 2 H), 7.14 (t, J = 8.6 Hz, 2 H), 4.14 (t, J = 9.4 Hz, 1 H), 3.58–3.61 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.2, 179.0, 169.1, 165.8, 135.3, 134.9, 131.7, 131.4, 131.0, 130.2, 130.1, 127.6, 122.4, 115.9, 85.5, 54.8, 40.8. HRMS (ESI): m/z [M + 2H]+ calcd for C19H13BrFN3O2S: 446.2928; found: 446.2933. 2-(3-Bromophenyl)-4-(4-chlorophenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3o) Yield: 83%; off-white solid; mp 212–214 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.70 (s, 1 H), 12.20 (s, 1 H), 8.09 (s, 1 H), 7.92 (d, J = 7.6 Hz, 1 H), 7.77 (d, J = 8 Hz, 1 H), 7.46–7.50 (m, 1 H), 7.37 (d, J = 8 Hz, 2 H), 7.19 (d, J = 8.8 Hz, 2 H), 4.15 (t, J = 9.2 Hz, 1 H), 3.59–3.61 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.2, 179.0, 169.0, 165.8, 135.3, 134.9, 134.7, 133.0, 131.4, 131.0, 130.0, 129.0, 127.7, 122.5, 85.5, 54.6, 40.7. HRMS (ESI): m/z [M + 2H]+ calcd for C19H13BrClN3O2S: 462.7474; found: 462.7478. 2,4-Bis(4-fluorophenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3p) Yield: 86%; off-white solid; mp 184–186 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.66 (s, 1 H), 12.16 (s, 1 H), 8.01 (dd, J = 8.4, 5.6 Hz, 2 H), 7.35 (t, J = 8.8 Hz, 2 H), 7.12–7.23 (m, 4 H), 4.14 (t, J = 9.4 Hz, 1 H), 3.56–3.61 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.0, 169.3, 166.1, 165.9, 131.2, 131.1, 130.2, 130.1, 116.3, 116.1, 115.9, 115.7, 85.5, 54.8, 40.9. HRMS (ESI): m/z [M + H]+ calcd for C19H13F2N3O2S: 386.0697; found: 386.0699. 4-(4-Chlorophenyl)-2-(4-fluorophenyl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3q) Yield: 85%; off-white solid; mp 224–226 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.71 (s, 1 H), 12.22 (s, 1 H), 8.01–8.04 (m, 2 H), 7.35–7.41 (m, 4 H), 7.21 (d, J = 8.4 Hz, 2 H), 4.18 (t, J = 9.4 Hz, 1 H), 3.59–3.64 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.0, 169.2, 166.0, 163.4, 134.8, 132.9, 131.3, 131.2, 130.0, 129.8, 128.9, 116.3, 85.4, 54.5, 40.8. HRMS (ESI): m/z [M + H]+ calcd for C19H13ClFN3O2S: 402.0401; found: 402.0406. 4-(4-Fluorophenyl)-2-(thiophen-2-yl)-8-thioxo-1,7,9-triazaspiro[4,5]dec-1-ene-6,10-dione (3r) Yield: 86%; off-white solid; mp 194–196 °C. 1H NMR (DMSO-d 6, 400 MHz): δ = 12.63 (s, 1 H), 12.14 (s, 1 H), 7.85 (d, J = 4.8 Hz, 1 H), 7.70 (d, J = 2.8 Hz, 1 H), 7.11–7.23 (m, 5 H), 4.14 (t, J = 9.4 Hz, 1 H), 3.49–3.63 (m, 2 H). 13C NMR (DMSO-d 6, 400 MHz): δ = 179.0, 174.5, 169.2, 166.2, 137.4, 133.3, 132.5, 131.6, 130.2, 130.1, 128.6, 115.9, 85.2, 55.0, 41.3. HRMS (ESI): m/z [M + H]+ calcd for C17H12FN3O2S2: 374.0355; found: 374.0358.